Cargando…
Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
OBJECTIVES: SARS-CoV-2 antibody assays are needed for serological surveys and as a complement to molecular tests to confirm COVID-19. However, the kinetics of the humoral response against SARS-CoV-2 remains poorly described and relies on the performance of the different serological tests. METHODS: I...
Autores principales: | Tuaillon, E, Bolloré, K, Pisoni, A, Debiesse, S, Renault, C, Marie, S, Groc, S, Niels, C, Pansu, N, Dupuy, AM, Morquin, D, Foulongne, V, Bourdin, A, Le Moing, V, Van de Perre, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834649/ https://www.ncbi.nlm.nih.gov/pubmed/32504735 http://dx.doi.org/10.1016/j.jinf.2020.05.077 |
Ejemplares similares
-
QuantiFERON-TB Gold Plus Assay in Patients With Latent vs. Active Tuberculosis in a Low Incidence Setting: Level of IFN-γ, CD4/CD8 Responses, and Release of IL-2, IP-10, and MIG
por: Carrère-Kremer, Séverine, et al.
Publicado: (2022) -
Accuracy of real-time PCR and digital PCR for the monitoring of total HIV DNA under prolonged antiretroviral therapy
por: Renault, Constance, et al.
Publicado: (2022) -
The impact of targeting repetitive BamHI-W sequences on the sensitivity and precision of EBV DNA quantification
por: Sanosyan, Armen, et al.
Publicado: (2017) -
Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV
por: Ayouba, Ahidjo, et al.
Publicado: (2020) -
P07-11 LB. Impact of highly active antiretroviral therapy on cell-free and cell-associated HIV-1 in cervicovaginal secretions and blood
por: Rubbo, P, et al.
Publicado: (2009)